Mukesh Khanna gets trolled as he announces his return as Shaktimaan, fans say, 'It’s time to move on' Story: When two young men unleash violence in town and on his family, Giri takes action in ...

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...

But fashion mostly depends on the clothes which you are wearing. That is why many brands have created different types of t-shirts, shirts, and more unique styles and qualities to explain the ...

T-Mobile is the third-largest wireless carrier in the United States, with its popularity largely down to its network coverage and the wide range of tempting offers available. They span from T ...

It’s time to get shirty. Arket's shirts will work harder than any others in your wardrobe. Whether you wear them to work or on the weekends, there's a great selection of smart-casual heroes ...

Andrew is CNET's go-to guy for product coverage and lead photographer for Europe. When not testing the latest phones, he can normally be found with his camera in hand, behind his drums or eating ...

About a week later, the agency authorized an updated version of Novavax’s protein subunit vaccine for people 12 years and older. The mRNA vaccines specifically target KP.2, a subvariant of JN.

Baggy suits, baggy pants, baggy T-shirts—they're definitively cool, and it's time to start stocking up. Let your slim-cut T-shirts take a break for a little while, and don't be afraid of what an ...

Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined Covid-flu vaccine and standalone flu inoculation due to safety concerns.

In early pandemic days, Novavax (NASDAQ: NVAX) shares soared as investors bet on the company's ability to bring a coronavirus vaccine to market. But as the biotech fell behind in the race and ...

Novavax has been gearing up to launch a phase 3 trial of what may result in an important product: A combined flu and coronavirus vaccine. But the company now faces a roadblock, saying regulators ...